Tag: Public Offering
-

Medline Survives Delays on Road to Biggest US 2025 IPO
Medline Bets Big on a Delayed IPO Medline Inc., a leading medical supplies company, is moving closer to a landmark initial public offering despite a history of delays that kept the market guessing. With investors showing renewed appetite for healthcare-focused listings, Medline’s path to the public markets is increasingly viewed as worthwhile, enough to potentially…
-

Medline IPO Delays Prove No Barrier to a Record 2025 Listing
Medline’s Path to the Public Market Medline Inc., a leading name in the medical supply sector, has faced a winding road toward its much-anticipated initial public offering. After multiple postponements, the company is back on track with a plan that appears capable of delivering one of the largest U.S. listings of 2025. Investor interest in…
-

LIVE: Lenskart IPO Opens — GMP Surges to 17%: Issue Price & Key Details
Live Updates: Lenskart Solutions IPO Opens for Subscription The much-anticipated Lenskart Solutions IPO kicked off today, October 31, with investors watching the gray market premium (GMP) and the issue mechanics closely. As the bidding window opens, market participants are eyeing the upper end of the price band and the stock’s potential listing performance. The public…
-

Tata Capital IPO Listing: A 1% Premium, Long-Term Prospects Under Analysts’ Lens
Tata Capital IPO Listing: What Investors Need to Know The Tata Capital IPO is now a live event as the company begins trading on major Indian exchanges. With shares reportedly listing at a 1% premium over the IPO price, investors are weighing the mix of growth potential, risk controls, and the group’s broader financial services…
-

LIVE coverage: Tata Capital IPO Day 2 — What investors should know as bidding continues
Live Update: Tata Capital IPO enters Day 2 of bidding The Tata Capital IPO opened on October 6 and is now in its second day of public subscription. With a fresh issue and an Offer for Sale (OFS), the financial services arm of the Tata Group aims to raise about Rs 15,512 crore, making it…
-

Alpha Finance Increases METLEN Stock Target to €71
Introduction to METLEN’s Stock Performance In an insightful report released by Alpha Finance, the investment firm has raised the target price for METLEN shares to €71. This significant adjustment underscores the optimism surrounding METLEN, especially following its notable entry onto the London Stock Exchange (LSE) in early September 2025. Milestones Achieved by METLEN METLEN has…

